Page last updated: 2024-08-17

apomorphine and Dyskinesia, Drug-Induced

apomorphine has been researched along with Dyskinesia, Drug-Induced in 155 studies

Research

Studies (155)

Timeframe	Studies, this research(%)	All Research%
pre-1990	70 (45.16)	18.7374
1990's	34 (21.94)	18.2507
2000's	33 (21.29)	29.6817
2010's	16 (10.32)	24.3611
2020's	2 (1.29)	2.80

Authors

Authors	Studies
Shao, M; Wang, R	1
Chaudhuri, KR; Deuschl, G; Henriksen, T; Katzenschlager, R; Lees, A; Lockhart, D; Poewe, W; Rascol, O; Staines, H; Trenkwalder, C; van Laar, T	1
Alam, M; Grothe, C; Jin, X; Krauss, JK; Ratzka, A; Rumpel, R; Schwabe, K; Tschirner, SK; von Wrangel, C	1
Du, CX; Liu, J; Sun, YN; Wang, HS; Wang, Y; Yao, L; Zhang, GJ; Zhang, L	1
Nagy, H; Radics, P; Takáts, A; Tamás, G; Tóth, A	1
Björklund, A; Carta, M; Devoto, P; Rogers, JT; Shin, E	1
Cui, G; Hua, F; Shen, X; Shi, H; Wang, X; Yang, X; Zhang, S; Zhang, W; Zhang, Z; Zhao, H; Zu, J	1
Fisher, R; Jackson, MJ; Jenner, P; Lees, AJ; Lincoln, L; Neumeyer, J; Rose, S; Sromek, AW	1
Bez, F; Cenci, MA; Francardo, V	1
Bhidayasiri, R; Garcia Ruiz, PJ; Henriksen, T	1
Aguilar, E; Bartoszyk, GD; Marin, C; Obeso, JA; Rodríguez-Oroz, MC	1
Björklund, A; Carlsson, T; Carta, M; Kirik, D; Muñoz, A; Tronci, E	1
Kunselman, AR; Lieu, CA; Manyam, BV; Subramanian, T; Venkiteswaran, K	1
Kirik, D; Sahin, G; Ulusoy, A	1
Gao, DM; Jiao, JJ; Zhuang, XY	1
Af Bjerkén, S; Gerhardt, GA; Lundblad, M; Nevalainen, N; Strömberg, I	1
Carlsson, T; Döbrössy, M; García, J; Nikkhah, G; Winkler, C	1
Dunnett, SB; Heuer, A; Lane, EL; Smith, GA	1
Geng, XC; Yin, LL; Zhu, XZ	1
Bishop, C; Buchta, W; Dickinson, SO; Eissa, S; Eskow Jaunarajs, KL; George, JA; Goldenberg, AA; Mohamed, M	1
Bezard, E; Björklund, A; Carta, M; Li, Q; Pioli, EY; Porras, G; Tronci, E	1
Lees, AJ; Manson, AJ; Turner, K	1
Cannizzaro, C; Jackson, MJ; Jenner, P; Maratos, EC; Pearce, RK	1
Gudín, M; Hernández, A; Ibáñez, R; Vaamonde, J	1
Bibbiani, F; Castagnoli, N; Chase, TN; Chen, JF; Oh, JD; Petzer, JP; Schwarzschild, MA	1
Swope, DM	1
Bergman, H; Fainstein, N; Morris, G; Nevet, A; Saban, G	1
Happe, S; Meller, J; Paulus, W; Sommer, M; Trenkwalder, C	1
Fairfax, DF; Gupta, SK; Henry, P; Khan, RF; Mishra, RK; N-Marandi, S; Rogoza, RM	1
Axelrod, JD; Barghshoon, S; Chen, CK; Cheyette, BN; Ebert, J; Kovoor, A; Lester, HA; Schwarz, J; Schwarz, S; Seyffarth, P; Simon, MI	1
Gerlach, M; Reichmann, H; Riederer, P	1
Brusa, L; Caltagirone, C; Centonze, D; Koch, G; Oliveri, M; Peppe, A; Stanzione, P	1
Hedrich, K; Kann, M; Kis, B; Klein, C; Kömpf, D; Pramstaller, PP; Schwinger, E	1
Alegre, M; Alonso-Frech, F; Artieda, J; Guridi, J; Manrique, M; Obeso, JA; Rodríguez-Oroz, MC; Valencia, M; Zamarbide, I	1
Chen, JJ; Obering, CD; Swope, DM	1
Chesselet, MF; Fleming, SM; Hutson, CB; Levine, MS; Masliah, E; Rockenstein, E; Salcedo, J	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V	1
Bottini, PB; Gutmann, L; Hull, KL; Pfeiffer, RF; Sherry, JH	1
Dougherty, PM; Kim, JH; Lee, JI; Lenz, FA; Ohara, S; Verhagen Metman, L	1
Ludin, HP; Surber, Ch	1
Glassman, HN; Glassman, RB	1
Engel, J; Goldstein, M; Liljequist, S	1
Beilstein, BA; Davis, KL; Kastin, AJ; Vento, AL	1
Christensen, AV; Nielsen, IM	2
Clow, A; Jenner, P; Kolbe, H; Marsden, CD	1
Gómez, A; Pesenti, L; Troncoso San Martín, E	1
Carvey, P; Goetz, CG; Klawans, HL	2
Bourne, RC; Cross, AJ; Gamble, SJ; Waddington, JL	1
Bucher, B; Dorme, N; Jalfre, M; Mocquet, G; Porsolt, RD	1
Casey, DE; Gerlach, J	1
Wagner, HN	1
Ackenheil, M; Albus, M; May, G; Müller-Spahn, F; Naber, D; Welter, D; Zander, K	1
Friedhoff, AJ; Rosengarten, H; Schweitzer, JW	2
Curtin, J; Fields, J; Koller, W	1
Abou Zeit-Har, MS; Arnerić, SP; Long, JP; Verimer, T; Walsh, BJ	1
Davis, BM; Davis, KL; Horvath, TB; Kendler, KS; Levy, MI; Mathé, AA; Mohs, RC; Trigos, G	1
Offermeier, J; van Rooyen, JM	1
Bjørndal, N; Christensson, E; Gerlach, J	1
Bédard, PJ; Boucher, R; Daigle, M; Di Paolo, T	1
Costall, B; Kelly, ME; Naylor, RJ	1
Alanen, E; Pohto, P; Sundén-Kuronen, B	1
Cutler, NR; Jeste, DV; Karoum, F; Kaufmann, CA	1
Bhargava, HN	1
Lerer, B	1
Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Kendler, KS; Levy, MI; Mathe, AA; Mohs, RC; Trigos, G	1
Margova, L; Toreva, D; Yonchev, A; Yonchev, V	1
Antolik, EK; Faison, EP; Yarbrough, GG	1
Broekkamp, CL	1
Markova, OF; Stoliarov, GV	1
Borison, RL; Diamond, BI; Gordon, JH	1
Clow, A; Jenner, P; Marsden, CD; Theodorou, A	1
Diamond, BI; Gordon, JH	1
Carvey, P; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Agid, Y; Blin, J; Bonnet, AM; Durif, F; Vidailhet, M	1
Crossman, AR; Page, RD; Sambrook, MA	1
Crabbe, J; Gancher, S; Garland, A; Lea, E; Woodward, W	1
Glenthøj, B	1
Malick, JB; Migler, BM; Warawa, EJ	1
Kaur, S; Starr, BS; Starr, MS	1
Chesselet, MF; Eberle-Wang, K; Lucki, I; Parry, TJ	1
Beal, MF; Cipolloni, PB; Ferrante, RJ; Kowall, NW; Storey, E	1
Deffond, D; Dordain, G; Durif, F; Tournilhac, M	1
Behrens, S; Emrich, A; Gattaz, WF	1
Oertel, WH; Quinn, NP	1
Bassi, A; Bernardi, G; Mazzone, P; Stanzione, P; Stefani, A; Vangelista, T	1
Joyce, JN; Neal-Beliveau, BS	1
Colzi, A; Lees, AJ; Turner, K	1
Betti, O; Cammarota, A; Leiguarda, R; Merello, M; Nouzeilles, MI	1
Agid, Y; Debilly, B; Durif, F; Vidailhet, M	1
Dalkara, T; Elibol, B; Erdem, S; Saka, E	1
Adachi, K; Cools, AR; Hasegawa, M; Hirose, N; Ikeda, H; Koshikawa, N; Sato, M	1
Fletcher, PJ; Kapur, S; Sills, TL; Wadenberg, MG	1
Dostrovsky, J; Hutchison, W; Lang, AE; Levy, R; Lozano, AM	1
Stoessl, AJ; Van Kampen, JM	1
Poewe, W; Wenning, GK	1
Jenner, P; Smith, LA; Treseder, SA	1
Bezard, E; Bioulac, B; Boraud, T; Gross, CE	1
Jacques, DB; Kopyov, O; Olds, ME	1
Gatos, GC; Kirkland, KM; McLaren, FM; Migler, BM; Needles, AL; Nelson, CL; Ohnmacht, CJ; Warawa, EJ	1
Brotchie, JM; Crossman, AR; Fox, SH; Henry, B; Hill, MP; Peggs, D	1
Bareš, M; Hortová, H; Kanovský, P; Kubová, D; Rektor, I; Streitová, H; Znojil, V	1
Brotchie, JM; Crossman, AR; Silverdale, MA	1
Carroll, BJ; Curtis, GC; Kokmen, E	1
Costall, B; Naylor, RJ; Nohria, V; Owen, RT	1
Horsman, L; Pullar, IA; Tye, NC; Wright, FC	1
Costentin, J	1
Fang, VS; Goode, DJ; Meltzer, HY; Schyve, P; Young, M	1
Beilstein, BA; Davis, KL; Hollister, LE; Rosekind, GR; Vento, AL	1
Carlson, KR	1
List, SJ; Seeman, P	1
Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ	1
Asano, T; Matsumoto, Y; Mimura, Y; Mino, S; Nishimoto, A; Ohmoto, T; Yoshimura, Y	1
Costall, B; Naylor, RJ; Owen, RT	1
Davis, KL; Hollister, LE; Simonton, S; Vento, AL	1
Klawans, HL; Nausieda, PA; Weiner, WJ	1
Goetz, C; Klawans, HL; Nausieda, PA; Weiner, WJ	1
Tolosa, ES	1
Agnoli, A; Forchetti, C; Ruggieri, S; Scarnati, E	1
Klawans, HL; Moskovitz, C	1
Ali, SI; Davis, JM; Ericksen, S; Garver, DL; Pandey, GN; Tamminga, C	1
Davis, JM; Haraszti, J; Pandey, GN; Smith, RC; Tamminga, CA	1
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC	1
Allen, RM	1
Davis, JM; Frohman, LA; Pandey, G; Smith, RC; Tamminga, CA	1
Cervantes, P; Ettigi, P; Guyda, H; Lal, S; Nair, NP	1
Bertolucci, PH; De Andrade, LA; Ferraz, HB; Pereira, JS	1
Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J	1
Gerlach, J; Lublin, H; Peacock, L	1
Albani, C; Fischer, G; Zangger, I	1
Chen, S	1
Csernansky, JG; Newcomer, JW; Riney, SJ; Vinogradov, S	1
Jenkins, JR; Pearce, JM	1
de Saint Victor, JF; Gervason, CL; Perret, J; Pollak, P	1
Drucker, GE; Fields, JZ; Gordon, JH; Wichlinski, L	1
Haba, K; Mizukawa, K; Ogawa, N; Sato, H	1
Kleedorfer, B; Lees, AJ; Stern, GM	1
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ	1
Hantraye, P; Isacson, O; Maziere, M; Riche, D; Sofroniew, MV	1
Bakay, RA; Byrd, LD; Colbassani, HJ; Herring, CJ; Iuvone, PM; Mandir, A; Sweeney, KM; Watts, RL	1
Jansen, EN; van Laar, T	1
Gunne, LM; Häggström, JE; Johansson, P; Levin, ED; Terenius, L	1
Forster, C; Herrera-Marschitz, M; Ungerstedt, U	1
Carvey, P; Goetz, CG; Klawans, HL; Tanner, CM	1
Defazio, G; Di Reda, N; Giovine, A; Lanzi, C; Lepore, V; Livrea, P; Pedone, D; Tartaglione, B	1
Horowski, R; Marsden, CD; Obeso, JA	1
Bédard, PJ; Bouchard, S; Boucher, R; Di Paolo, T; Falardeau, P	1
Gerlach, J; Lublin, H	1
Hietala, J; Pihlajamäki, K; Säkö, E; Scheinin, M; Syvälahti, EK	1
Costall, B; Holmes, SW; Kelly, ME; Naylor, RJ	1
Gerber, R; Gerhardt, S; Liebman, JM	1
Bédard, PJ; Boucher, R	1
Sundén-Kuronen, B	1

Reviews

12 review(s) available for apomorphine and Dyskinesia, Drug-Induced

Article	Year
[Treatment possibilities in advanced Parkinson's disease]. Ideggyogyaszati szemle, 2013, Nov-30, Volume: 66, Issue:11-12 Topics: Administration, Oral; Age Factors; Antiparkinson Agents; Apomorphine; Carbidopa; Cognition Disorders; Deep Brain Stimulation; Dopamine Agents; Drug Tolerance; Duodenum; Dyskinesia, Drug-Induced; Gels; Humans; Infusion Pumps, Implantable; Levodopa; Parkinson Disease; Quality of Life; Severity of Illness Index	2013
Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:9 Topics: Animals; Apomorphine; Aporphines; Behavior, Animal; Callithrix; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Male; MPTP Poisoning; Valerates	2016
Practical management of adverse events related to apomorphine therapy. Parkinsonism & related disorders, 2016, Volume: 33 Suppl 1 Topics: Animals; Antiparkinson Agents; Apomorphine; Arrhythmias, Cardiac; Disease Management; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Parkinson Disease; Vomiting	2016
Rapid treatment of "wearing off" in Parkinson's disease. Neurology, 2004, Mar-23, Volume: 62, Issue:6 Suppl 4 Topics: Antiemetics; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parkinson Disease; Salvage Therapy; Time Factors	2004
Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease. Pharmacotherapy, 2006, Volume: 26, Issue:6 Topics: Antiparkinson Agents; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Humans; Models, Biological; Molecular Structure; Parkinson Disease	2006
[Prevention and treatment of fluctuations in patients with Parkinson's disease]. Praxis, 2006, Dec-20, Volume: 95, Issue:51-52 Topics: Antiparkinson Agents; Apomorphine; Carbidopa; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dopamine Agonists; Drug Administration Routes; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Infusion Pumps, Implantable; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Examination; Parkinson Disease; Treatment Outcome	2006
Animal models of tardive dyskinesia: their use in the search for new treatment methods. Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Age Factors; Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Carbidopa; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Combinations; Drug Interactions; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Haplorhini; Humans; Levodopa; Lithium; Male; Parasympatholytics; Rats; Receptors, Dopamine; Stereotyped Behavior	1983
Parkinson's disease: drug therapy. Bailliere's clinical neurology, 1997, Volume: 6, Issue:1 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Cholinergic Antagonists; Dopamine Agonists; Dyskinesia, Drug-Induced; Guidelines as Topic; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Treatment Outcome	1997
Apomorphine: an underutilized therapy for Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: Antiparkinson Agents; Apomorphine; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Subcutaneous; Parkinson Disease; Treatment Outcome	2000
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation]. L'Encephale, 1979, Volume: 5, Issue:2 Topics: Acetylcholine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior; Corpus Striatum; Dogs; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hypothermia; Levodopa; Memory; Mice; Opioid-Related Disorders; Parkinson Disease; Psychotic Disorders; Rats; Receptors, Dopamine; Sleep; Stereotyped Behavior; Substantia Nigra; Synapses; Synaptic Transmission	1979
Neurobiochemical changes in tardive dyskinesia. L'Encephale, 1988, Volume: 14 Spec No Topics: Animals; Antipsychotic Agents; Apomorphine; Cebus; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Rats; Substance P; Substantia Nigra	1988
Continuous dopaminergic stimulation: state of the art and outlook. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Antiparkinson Agents; Apomorphine; Dopamine; Drug Tolerance; Dyskinesia, Drug-Induced; Humans; Infusion Pumps; Lisuride; Mental Disorders; Movement; Neurology; Parkinson Disease; Stimulation, Chemical	1988

Trials

7 trial(s) available for apomorphine and Dyskinesia, Drug-Induced

Article	Year
Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO study. Parkinsonism & related disorders, 2021, Volume: 83 Topics: Aged; Apomorphine; Dopamine Agonists; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Female; Humans; Infusions, Subcutaneous; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease	2021
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology, 2005, Aug-23, Volume: 65, Issue:4 Topics: Aged; Apomorphine; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Motor Cortex; Neural Pathways; Parkinson Disease; Recovery of Function; Transcranial Magnetic Stimulation; Treatment Outcome	2005
Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease. Parkinsonism & related disorders, 2007, Volume: 13, Issue:2 Topics: Aged; Antiparkinson Agents; Apomorphine; Case-Control Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Parkinson Disease; Prospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2007
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. Archives of general psychiatry, 1984, Volume: 41, Issue:5 Topics: Adult; Apomorphine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Growth Hormone; Homovanillic Acid; Humans; Male; Placebos; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology	1984
Apomorphine and schizophrenia. Psychopharmacology bulletin, 1984,Winter, Volume: 20, Issue:1 Topics: Adult; Apomorphine; Dyskinesia, Drug-Induced; Homovanillic Acid; Hormones; Humans; Male; Middle Aged; Schizophrenia	1984
Levodopa-induced diphasic dyskinesias improved by subcutaneous apomorphine. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:3 Topics: Adult; Apomorphine; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Single-Blind Method	1992
Effects of intravenous and subcutaneous administration of apomorphine on the clinical symptoms of chronic schizophrenics. The British journal of psychiatry : the journal of mental science, 1986, Volume: 148 Topics: Adult; Apomorphine; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Schizophrenia; Schizophrenic Psychology	1986

Other Studies

136 other study(ies) available for apomorphine and Dyskinesia, Drug-Induced

Article	Year
L-DOPA-elicited abnormal involuntary movements in the rats damaged severely in substantia nigra by 6-hydroxydopamine. Annals of palliative medicine, 2020, Volume: 9, Issue:3 Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Oxidopamine; Rats; Substantia Nigra	2020
Altered somatosensory cortex neuronal activity in a rat model of Parkinson's disease and levodopa-induced dyskinesias. Experimental neurology, 2017, Volume: 294 Topics: Action Potentials; Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Glutamate Decarboxylase; Levodopa; Motor Cortex; Nerve Tissue Proteins; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, GABA; RNA, Messenger; Sympatholytics; Tandem Mass Spectrometry	2017
Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson's disease by metabolomic technology. Behavioural brain research, 2018, 07-16, Volume: 347 Topics: Animals; Antiparkinson Agents; Apomorphine; Arachidonic Acids; Biomarkers; Cannabinoid Receptor Agonists; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Endocannabinoids; Glycerides; Levodopa; Male; Metabolome; Metabolomics; Motor Activity; Oxidopamine; Parkinsonian Disorders; Polyunsaturated Alkamides; Rats, Sprague-Dawley	2018
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. Experimental neurology, 2014, Volume: 257 Topics: Adrenergic Agents; Adrenergic Neurons; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benzylamines; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Levodopa; Motor Activity; Nerve Degeneration; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Stereotyped Behavior	2014
Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease. Experimental neurology, 2015, Volume: 271 Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Gene Expression Regulation; Indoles; Levodopa; Male; MAP Kinase Signaling System; Motor Activity; Neurokinin-1 Receptor Antagonists; Oxidopamine; Parkinson Disease; Piperidines; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors	2015
Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion. Neurobiology of disease, 2016, Volume: 94 Topics: Aging; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Mice, Inbred C57BL; Motor Activity; Oxidopamine; Parkinson Disease	2016
Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats. Psychopharmacology, 2009, Volume: 204, Issue:2 Topics: Animals; Apomorphine; Benserazide; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Immunohistochemistry; Levodopa; Male; Microinjections; Organic Chemicals; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Rotation; Serotonin Receptor Agonists; Stereotyped Behavior; Subthalamic Nucleus; Sympathectomy, Chemical; Sympatholytics	2009
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Experimental neurology, 2009, Volume: 219, Issue:1 Topics: Animals; Apomorphine; Brain; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Levodopa; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists	2009
A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism & related disorders, 2010, Volume: 16, Issue:7 Topics: Analysis of Variance; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Forelimb; Mucuna; Oxidopamine; Parkinsonian Disorders; Phytotherapy; Plant Extracts; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Rotation; Time Factors; Tyrosine 3-Monooxygenase; Vibrissae	2010
Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats. Proceedings of the National Academy of Sciences of the United States of America, 2010, Jul-20, Volume: 107, Issue:29 Topics: Animals; Apomorphine; Chromatography, High Pressure Liquid; Dependovirus; Disease Susceptibility; Dopamine; Down-Regulation; Dyskinesia, Drug-Induced; Female; Gene Knockdown Techniques; Levodopa; Microdialysis; Neostriatum; Neurons; Presynaptic Terminals; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Recombination, Genetic; RNA, Small Interfering; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase	2010
[The effects of intranigral microinjection of substance P on apomorphine-induced rotational behavior in 6-OHDA lesions rats]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2001, Volume: 17, Issue:4 Topics: Animals; Apomorphine; Behavior, Animal; Dyskinesia, Drug-Induced; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Rotation; Substance P; Substantia Nigra	2001
Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. Journal of neurochemistry, 2011, Volume: 118, Issue:1 Topics: Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopa Decarboxylase; Dopamine; Dyskinesia, Drug-Induced; Electrochemistry; Female; Functional Laterality; Levodopa; Oxidopamine; Potassium Chloride; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Stereotyped Behavior; Tyrosine 3-Monooxygenase	2011
Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation. Experimental neurology, 2011, Volume: 232, Issue:2 Topics: Amphetamines; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Dyskinesias; Female; Fetal Tissue Transplantation; Levodopa; Oxidopamine; Postoperative Complications; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Substantia Nigra; Sympatholytics	2011
Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia. Behavioural brain research, 2012, Jan-01, Volume: 226, Issue:1 Topics: Adrenergic Agents; Animals; Apomorphine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Mice; Motor Activity; Neurons; Oxidopamine; Rotarod Performance Test; Substantia Nigra	2012
The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model. Brain research bulletin, 2011, Nov-25, Volume: 86, Issue:5-6 Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Benserazide; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RGS Proteins	2011
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. The European journal of neuroscience, 2012, Volume: 36, Issue:6 Topics: Animals; Antiparkinson Agents; Apomorphine; Biogenic Monoamines; Citalopram; Corpus Striatum; Dyskinesia, Drug-Induced; Fluoxetine; Levodopa; Male; Parkinsonian Disorders; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors	2012
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:8 Topics: Amantadine; Amphetamine; Animals; Apomorphine; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors; Tyrosine 3-Monooxygenase	2013
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Infusion Pumps; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease; Treatment Outcome	2002
Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus). Experimental neurology, 2003, Volume: 179, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Motor Activity; Parkinsonian Disorders; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Severity of Illness Index	2003
[Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients]. Neurologia (Barcelona, Spain), 2003, Volume: 18, Issue:3 Topics: Aged; Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors	2003
A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Experimental neurology, 2003, Volume: 184, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Apomorphine; Denervation; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Macaca fascicularis; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Phosphorylation; Purines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Dopamine D1; Receptors, Dopamine D2; Sympatholytics	2003
Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. Journal of neurophysiology, 2004, Volume: 92, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Electrophysiology; Female; Globus Pallidus; Macaca; Neurons; Parkinson Disease, Secondary; Substantia Nigra	2004
Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:1 Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia; Dyskinesia, Drug-Induced; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Tomography, Emission-Computed, Single-Photon	2005
Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse (New York, N.Y.), 2004, Dec-01, Volume: 54, Issue:3 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Binding Sites; Corpus Striatum; Cyclic N-Oxides; Disease Models, Animal; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug-Induced; Electron Spin Resonance Spectroscopy; Haloperidol; Humans; Male; Mastication; Motor Activity; Movement Disorders; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine D2	2004
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Feb-23, Volume: 25, Issue:8 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Mice; Mice, Knockout; Movement Disorders; Parkinson Disease; Patch-Clamp Techniques; Protein Interaction Mapping; Protein Structure, Tertiary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reserpine; RGS Proteins; Subcellular Fractions; Sulpiride; Transfection	2005
Levodopa in the treatment of Parkinson's disease: current controversies. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide	2005
Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications. Neurology, 2005, Sep-13, Volume: 65, Issue:5 Topics: Age of Onset; Antiparkinson Agents; Apomorphine; Basal Ganglia; Calcinosis; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; Humans; Levodopa; Middle Aged; Ocular Motility Disorders; Oculomotor Muscles; Parkinsonian Disorders	2005
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain : a journal of neurology, 2006, Volume: 129, Issue:Pt 7 Topics: Action Potentials; Adult; Aged; Antiparkinson Agents; Apomorphine; Biological Clocks; Combined Modality Therapy; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Electrodes, Implanted; Humans; Levodopa; Middle Aged; Parkinson Disease; Subthalamic Nucleus	2006
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience, 2006, Nov-03, Volume: 142, Issue:4 Topics: alpha-Synuclein; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benserazide; Brain; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Genetic Predisposition to Disease; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Parkinson Disease; Stereotypic Movement Disorder	2006
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior	2006
Internal pallidal neuronal activity during mild drug-related dyskinesias in Parkinson's disease: decreased firing rates and altered firing patterns. Journal of neurophysiology, 2007, Volume: 97, Issue:4 Topics: Aged; Antiparkinson Agents; Apomorphine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electric Stimulation; Electromyography; Electrophysiology; Female; Globus Pallidus; Humans; Intraoperative Period; Male; Microelectrodes; Middle Aged; Models, Neurological; Models, Statistical; Neurons; Neurosurgical Procedures; Parkinson Disease; Poisson Distribution; Postoperative Period	2007
Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology, 1980, Volume: 69, Issue:1 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Mouth Diseases; Movement Disorders; Occipital Lobe; Rats; Substance Withdrawal Syndrome	1980
Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms. Advances in biochemical psychopharmacology, 1980, Volume: 23 Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Female; Limbic System; Methyltyrosines; Mice; Motor Activity; Penfluridol; Receptors, Dopamine; Tyrosine 3-Monooxygenase	1980
MSH and MIF-I in animal models of tardive dyskinesia. Pharmacology, biochemistry, and behavior, 1980, Volume: 13, Issue:1 Topics: Animals; Apomorphine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Melanocyte-Stimulating Hormones; Motor Activity; MSH Release-Inhibiting Hormone; Rats; Stereotyped Behavior	1980
Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia. Advances in biochemical psychopharmacology, 1980, Volume: 24 Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Methylphenidate; Mice; Stereotyped Behavior; Time Factors	1980
Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology, 1981, Volume: 31, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Erythrocytes; Homovanillic Acid; Male; Phenothiazines; Rats; Receptors, Dopamine; Synapses; Synaptic Transmission	1981
[Hypersensitivity to apomorphine in rats treated with neuroleptics: a model of tardive dyskinesia]. Revista medica de Chile, 1982, Volume: 110, Issue:4 Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Drug Hypersensitivity; Drug Interactions; Dyskinesia, Drug-Induced; Female; Rats; Rats, Inbred Strains	1982
Animal models of tardive dyskinesias. Clinical neuropharmacology, 1983, Volume: 6, Issue:2 Topics: Animals; Antipsychotic Agents; Apomorphine; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug-Induced; Epidemiologic Methods; Guinea Pigs; Haloperidol; Humans; Time Factors	1983
Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments. Advances in biochemical psychopharmacology, 1983, Volume: 37 Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Dyskinesia, Drug-Induced; Humans; Male; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior	1983
Neuropharmacological profile of MD 790501, a new benzamide derivative. Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 264, Issue:2 Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Central Nervous System; Dogs; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Macaca mulatta; Male; Mice; Motor Activity; Norepinephrine; Nortropanes; Rats; Rats, Inbred Strains; Stereotyped Behavior	1983
Dopamine agonists in clinical research for new tardive dyskinesia treatments. Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Benserazide; Carbidopa; Dopamine; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Synaptic Transmission	1983
Imaging CNS receptors: the dopaminergic system. Hospital practice (Office ed.), 1984, Volume: 19, Issue:6 Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium	1984
Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia. Psychopharmacology, 1984, Volume: 84, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prolactin; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Time Factors	1984
Induction of oral dyskinesias in naive rats by D1 stimulation. Life sciences, 1983, Dec-19, Volume: 33, Issue:25 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dyskinesia, Drug-Induced; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Sulpiride	1983
Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia. Neuropharmacology, 1984, Volume: 23, Issue:10 Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Humans; Indoles; Male; Molindone; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior	1984
Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats. Psychopharmacology, 1981, Volume: 75, Issue:3 Topics: Animals; Apomorphine; Castration; Chlorides; Dyskinesia, Drug-Induced; Estrogens; Female; Humans; Lithium; Lithium Chloride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sex Factors; Stereotyped Behavior	1981
Dopamine inhibitory and excitatory systems in tardive dyskinesias. Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Animals; Apomorphine; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Hydroxydopamines; Male; Nucleus Accumbens; Oxidopamine; Piribedil; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride	1983
Methylphenidate, apomorphine, THIP, and diazepam in monkeys: dopamine-GABA behavior related to psychoses and tardive dyskinesia. Psychopharmacology, 1984, Volume: 82, Issue:1-2 Topics: Animals; Apomorphine; Chlorocebus aethiops; Diazepam; Dopamine; Drug Interactions; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Isoxazoles; Male; Methylphenidate; Motor Activity; Oxazoles; Psychoses, Substance-Induced	1984
Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendocrinology, 1984, Volume: 9, Issue:4 Topics: Animals; Apomorphine; Drug Interactions; Dyskinesia, Drug-Induced; Estradiol; Female; Haloperidol; Macaca fascicularis; Receptors, Dopamine; Spiperone	1984
The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent. British journal of pharmacology, 1984, Volume: 83, Issue:3 Topics: 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Animals; Apomorphine; Aspirin; Catalepsy; Corpus Striatum; Dopamine Antagonists; Dyskinesia, Drug-Induced; Fatty Acids, Unsaturated; Guinea Pigs; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior	1984
Oral tardive dyskinesia in the rat. Acta odontologica Scandinavica, 1983, Volume: 41, Issue:6 Topics: Animals; Apomorphine; Bruxism; Dental Occlusion, Traumatic; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Time Factors	1983
Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders. Biological psychiatry, 1983, Volume: 18, Issue:9 Topics: Adult; Apomorphine; Bromocriptine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Male	1983
Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia? Modern problems of pharmacopsychiatry, 1983, Volume: 21 Topics: Animals; Apomorphine; Corpus Striatum; Dipeptides; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Male; Mice; Neuropeptides; Peptides, Cyclic; Spiperone	1983
ECT and tardive dyskinesia. The Journal of clinical psychiatry, 1984, Volume: 45, Issue:4 Topics: Animals; Apomorphine; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Haloperidol; Humans; Rats; Receptors, Dopamine	1984
The effect of some neurotropic drugs on neuroleptic hypersensitivity of dopamine receptors in the central nervous system. Folia medica, 1980, Volume: 22, Issue:1 Topics: Adenosine Triphosphate; Animals; Apomorphine; Corpus Striatum; Cyclophosphamide; Drug Hypersensitivity; Dyskinesia, Drug-Induced; Haloperidol; Imipramine; Male; Parasympatholytics; Piracetam; Rats; Receptors, Dopamine; Trihexyphenidyl	1980
MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia. Neuroscience letters, 1982, Dec-31, Volume: 34, Issue:3 Topics: Animals; Apomorphine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Thiazolidines; Thyrotropin-Releasing Hormone	1982
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants. Life sciences, 1982, Dec-20, Volume: 31, Issue:25 Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nomifensine; Piribedil; Receptors, Dopamine; Stereotyped Behavior	1982
[Apomorphine in dyskinesia and psychomotor agitation]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1982, Volume: 82, Issue:8 Topics: Adolescent; Adult; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Movement Disorders; Psychomotor Agitation; Schizophrenia	1982
Estrogen in experimental tardive dyskinesia. Neurology, 1980, Volume: 30, Issue:5 Topics: Animals; Apomorphine; Castration; Dyskinesia, Drug-Induced; Estradiol; Female; Haloperidol; Humans; Rats; Receptors, Dopamine; Stereotyped Behavior; Substance Withdrawal Syndrome	1980
Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal. Advances in biochemical psychopharmacology, 1980, Volume: 24 Topics: Adenylyl Cyclases; Animals; Apomorphine; Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Humans; Male; Rats; Spiperone; Stereotyped Behavior; Substance Withdrawal Syndrome; Thioridazine; Time Factors; Trifluoperazine	1980
Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biological psychiatry, 1981, Volume: 16, Issue:4 Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Estradiol; Female; Haloperidol; Humans; Rats; Receptors, Dopamine; Stereotyped Behavior; Substance Withdrawal Syndrome	1981
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life sciences, 1981, May-11, Volume: 28, Issue:19 Topics: Animals; Apomorphine; Behavior, Animal; Carbidopa; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Humans; Levodopa; Male; Stereotyped Behavior; Time Factors	1981
Levodopa-induced dyskinesias are improved by fluoxetine. Neurology, 1995, Volume: 45, Issue:10 Topics: Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Levodopa; Middle Aged	1995
Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey. Neuroscience, 1993, Volume: 55, Issue:1 Topics: Afferent Pathways; Animals; Apomorphine; Axonal Transport; Brain Mapping; Chorea; Dyskinesia, Drug-Induced; Dystonia; Globus Pallidus; Horseradish Peroxidase; Levodopa; Macaca fascicularis; MPTP Poisoning; Parkinson Disease, Secondary; Stereotaxic Techniques; Thalamus; Wheat Germ Agglutinins	1993
Dose- and duration-dependent tolerance to rotational effects of apomorphine in a rat model of Parkinsonism. The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:1 Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Dyskinesia, Drug-Induced; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley	1995
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function. Psychopharmacology, 1993, Volume: 113, Issue:2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Male; Parasympathetic Nervous System; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine; Stereotyped Behavior	1993
Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacology, biochemistry, and behavior, 1994, Volume: 49, Issue:3 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Cyclic AMP; Dyskinesia, Drug-Induced; Female; Fluphenazine; In Vitro Techniques; Male; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior	1994
Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drug. Psychopharmacology, 1993, Volume: 112, Issue:2-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Basal Ganglia Diseases; Behavior, Animal; Catalepsy; Cats; Cebus; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Fixation, Ocular; Male; Mice; Motor Activity; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Saimiri; Stereotyped Behavior; Swimming	1993
Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse. Journal of neural transmission. Parkinson's disease and dementia section, 1994, Volume: 8, Issue:1-2 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Levodopa; Male; Mice; Motor Activity; Receptors, Dopamine; Reserpine	1994
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Experimental neurology, 1994, Volume: 128, Issue:2 Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dyskinesia, Drug-Induced; Haloperidol; Kainic Acid; Male; Mouth Diseases; Rats; Rats, Sprague-Dawley; Sulpiride; Thalamic Nuclei	1994
Movement disorder following excitotoxin lesions in primates. Neuroreport, 1994, Jun-02, Volume: 5, Issue:10 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dyskinesia, Drug-Induced; Macaca mulatta; Quinolinic Acid	1994
Apomorphine and diphasic dyskinesia. Clinical neuropharmacology, 1994, Volume: 17, Issue:1 Topics: Aged; Apomorphine; Circadian Rhythm; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1994
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia. Journal of neural transmission. General section, 1993, Volume: 92, Issue:2-3 Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dyskinesia, Drug-Induced; Grooming; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Vitamin E	1993
Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. Short communication. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:8-9 Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; Globus Pallidus; Humans; Intraoperative Period; Levodopa; Male; Middle Aged; Parkinson Disease; Stereotaxic Techniques	1997
Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Developmental psychobiology, 1998, Volume: 32, Issue:4 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Corpus Striatum; Critical Period, Psychological; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Grooming; Male; Motor Activity; Mouth; Observation; Oxidopamine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Self-Injurious Behavior; Stereotyped Behavior	1998
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:5 Topics: Aged; Antiparkinson Agents; Apomorphine; Chronotherapy; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Infusion Pumps, Implantable; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Treatment Outcome	1998
Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:3 Topics: Aged; Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Globus Pallidus; Humans; Intraoperative Complications; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Sensitivity and Specificity; Treatment Outcome	1998
Worsening of levodopa-induced dyskinesias by motor and mental tasks. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:2 Topics: Analysis of Variance; Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Problem Solving; Severity of Illness Index; Speech; Volition	1999
Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment. Brain research, 1999, Apr-17, Volume: 825, Issue:1-2 Topics: Animals; Apomorphine; Behavior, Animal; Calbindins; Corpus Striatum; Denervation; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Male; Nerve Tissue Proteins; Neuronal Plasticity; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; S100 Calcium Binding Protein G; Sympatholytics	1999
Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:11-12 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Clozapine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Jaw; Male; Mastication; Quinpirole; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Serotonin Antagonists	1999
Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats. Biological psychiatry, 2000, Apr-01, Volume: 47, Issue:7 Topics: Acoustic Stimulation; Amoxapine; Analysis of Variance; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Dyskinesia, Drug-Induced; Indophenol; Male; Proactive Inhibition; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists	2000
Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Annals of neurology, 2000, Volume: 47, Issue:4 Suppl 1 Topics: Action Potentials; Affect; Apomorphine; Dopamine Agonists; Dyskinesia, Drug-Induced; Electrophysiology; Globus Pallidus; Humans; Neurons; Parkinson Disease; Subthalamic Nucleus	2000
Effects of oligonucleotide antisense to dopamine D(1A) receptor messenger RNA in a rodent model of levodopa-induced dyskinesia. Neuroscience, 2000, Volume: 98, Issue:1 Topics: Animals; Antiparkinson Agents; Apomorphine; Autoradiography; Behavior, Animal; Cocaine; Denervation; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Gene Expression; Levodopa; Male; Oligonucleotides, Antisense; Oxidopamine; Phenotype; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Rotation; Substantia Nigra; Sympatholytics; Tritium	2000
Endogenous dopaminergic tone and dopamine agonist action. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; alpha-Methyltyrosine; Animals; Antiparkinson Agents; Apomorphine; Benzopyrans; Callithrix; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Levodopa; Locomotion; Male; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase	2000
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain : a journal of neurology, 2001, Volume: 124, Issue:Pt 3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Apomorphine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Macaca fascicularis; Neural Pathways; Neurons; Parkinsonian Disorders; Piribedil; Receptors, Dopamine D1; Receptors, Dopamine D2	2001
Entopeduncular lesions facilitate and thalamic lesions depress spontaneous and drug-evoked motor behavior in the hemiparkinsonian rat. Synapse (New York, N.Y.), 2001, Jun-01, Volume: 40, Issue:3 Topics: Amphetamine; Animals; Apomorphine; Denervation; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Entopeduncular Nucleus; Male; Motor Cortex; Neural Inhibition; Neural Pathways; Neurosurgical Procedures; Oxidopamine; Parkinsonian Disorders; Rats; Thalamus; Ventral Thalamic Nuclei	2001
Behavioral approach to nondyskinetic dopamine antagonists: identification of seroquel. Journal of medicinal chemistry, 2001, Feb-01, Volume: 44, Issue:3 Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Cebus; Dibenzothiazepines; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Male; Mice; Quetiapine Fumarate; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship	2001
Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Apomorphine; Callithrix; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Idazoxan; Levodopa; Male; Neurologic Examination; Neurons; Norepinephrine; Substantia Nigra	2001
Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:1 Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Treatment Outcome	2002
Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia. Experimental neurology, 2002, Volume: 174, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alanine; Animals; Apomorphine; Autoradiography; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Excitatory Amino Acid Agonists; Female; Ligands; Macaca mulatta; Male; Organ Specificity; Parkinson Disease, Secondary; Pyrimidines; Radioligand Assay; Receptors, AMPA	2002
Paradoxical response to dopamine agonists in tardive dyskinesia. The American journal of psychiatry, 1977, Volume: 134, Issue:7 Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine	1977
Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers. The Journal of pharmacy and pharmacology, 1978, Volume: 30, Issue:10 Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Mice; Motor Activity; Propranolol; Stereoisomerism; Sulpiride; Time Factors	1978
Differential enhancement of locomotor activity by dopamine agonists following chronic neuroleptic treatment: an animal model of tardive dyskinesia. European journal of pharmacology, 1979, Apr-01, Volume: 55, Issue:1 Topics: Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Ergolines; Male; Motor Activity; Rats; Time Factors	1979
Dopamine and schizophrenia. Lancet (London, England), 1976, Nov-20, Volume: 2, Issue:7995 Topics: Apomorphine; Dyskinesia, Drug-Induced; Humans; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents	1976
Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia. Psychopharmacology, 1979, Apr-11, Volume: 62, Issue:2 Topics: Animals; Antiparkinson Agents; Apomorphine; Atropine; Dopamine; Drug Synergism; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Male; Methylphenidate; Mice; Muscimol; Parasympatholytics; Parasympathomimetics; Phenobarbital; Physostigmine; Stereotyped Behavior	1979
Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia. Psychopharmacology, 1979, May-25, Volume: 63, Issue:2 Topics: Animals; Apomorphine; Behavior; Deanol; Dyskinesia, Drug-Induced; Ethanolamines; Humans; Male; Models, Psychological; Motor Activity; Rats; Stereotyped Behavior	1979
Supersensitivity to apomorphine and stress two years after chronic methadone treatment. Neuropharmacology, 1977, Volume: 16, Issue:11 Topics: Animals; Apomorphine; Behavior, Animal; Bruxism; Corpus Striatum; Dyskinesia, Drug-Induced; Haplorhini; Humans; Macaca mulatta; Male; Methadone; Receptors, Dopamine; Stress, Psychological	1977
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats. Life sciences, 1979, Apr-16, Volume: 24, Issue:16 Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone	1979
Clinical and experimental studies of phenytoin-induced hyperkinesias. Journal of neural transmission, 1979, Volume: 45, Issue:4 Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Drug Synergism; Dyskinesia, Drug-Induced; Female; Guinea Pigs; Haloperidol; Humans; Hyperkinesis; Male; Middle Aged; Phenytoin; Stereotyped Behavior	1979
Role of the caudate nucleus in production of dyskinesia [proceedings]. Applied neurophysiology, 1979, Volume: 42, Issue:5 Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Dyskinesia, Drug-Induced; Electric Stimulation; Levodopa; Movement Disorders; Neural Pathways; Substantia Nigra; Tremor	1979
Investigations into the nature of the peri-oral movements induced by 2-(N-N-dipropyl) amino-5,6-dihydroxytetralin. European journal of pharmacology, 1977, Oct-15, Volume: 45, Issue:4 Topics: 2-Naphthylamine; Animals; Apomorphine; Caudate Nucleus; Drug Interactions; Dyskinesia, Drug-Induced; Female; Guinea Pigs; Humans; Injections; Injections, Intraventricular; Male; Naphthalenes; Stereotyped Behavior; Tetrahydronaphthalenes	1977
Choline chloride in animal models of tardive dyskinesia. Life sciences, 1978, May-15, Volume: 22, Issue:19 Topics: Animals; Apomorphine; Choline; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Rats; Receptors, Dopamine; Stereotyped Behavior; Time Factors	1978
The effect of lithium on an animal model of tardive dyskinesia. Progress in neuro-psychopharmacology, 1977, Volume: 1, Issue:1-2 Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Humans; Lithium; Male; Receptors, Dopamine; Stereotyped Behavior	1977
Levodopa-induced dopamine receptor hypersensitivity. Transactions of the American Neurological Association, 1977, Volume: 102 Topics: Animals; Apomorphine; Dextroamphetamine; Disease Models, Animal; Dyskinesia, Drug-Induced; Humans; Levodopa; Mice; Receptors, Dopamine; Stereotyped Behavior	1977
Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors. Archives of neurology, 1978, Volume: 35, Issue:7 Topics: Adult; Aged; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Receptors, Dopamine; Spasm; Torticollis	1978
Evidence for an intrastriatal GABA control on motor activity arising from dopaminergic hyperfuction in the striatum. Acta neurologica, 1978, Volume: 33, Issue:4 Topics: Animals; Apomorphine; Corpus Striatum; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Hydroxydopamines; Male; Motor Activity; Rats; Receptors, Dopamine; Tubocurarine	1978
Cyclizine-induced chorea. Observations on the influence of cyclizine on dopamine-related movement disorders. Journal of the neurological sciences, 1977, Volume: 31, Issue:2 Topics: Aged; Amphetamine; Animals; Apomorphine; Behavior, Animal; Chorea; Cyclizine; Dyskinesia, Drug-Induced; Face; Female; Guinea Pigs; Humans; Male; Oxotremorine; Scopolamine; Scopolamine Derivatives; Stereotyped Behavior; Tremor	1977
Postsynaptic supersensitivity in schizophrenia. The American journal of psychiatry, 1977, Volume: 134, Issue:5 Topics: Acute Disease; Adenylyl Cyclases; Adolescent; Adult; Apomorphine; Blood Platelets; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Male; Prostaglandins E; Receptors, Dopamine; Schizophrenia	1977
Effects of dopamine agonists in tardive dyskinesia. The American journal of psychiatry, 1977, Volume: 134, Issue:7 Topics: Administration, Oral; Apomorphine; Brain; Dextroamphetamine; Dopamine; Dyskinesia, Drug-Induced; Growth Hormone; Humans; Injections, Intravenous; Injections, Subcutaneous; Prolactin; Receptors, Dopamine	1977
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia. The American journal of psychiatry, 1977, Volume: 134, Issue:7 Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia	1977
Dopamine hypersensitivity and tardive dyskinesia. The American journal of psychiatry, 1977, Volume: 134, Issue:10 Topics: Apomorphine; Drug Hypersensitivity; Dyskinesia, Drug-Induced; Humans; Receptors, Dopamine	1977
A neuroendocrine study of supersensitivity in tardive dyskinesia. Archives of general psychiatry, 1977, Volume: 34, Issue:10 Topics: Adult; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents	1977
Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy. Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:9 Topics: Adult; Aged; Apomorphine; Dyskinesia, Drug-Induced; Growth Hormone; Humans; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Time Factors; Tranquilizing Agents	1976
A study on the action of two calcium channel blockers (verapamil and flunarizine) upon an experimental model of tardive dyskinesia in rats. Arquivos de neuro-psiquiatria, 1992, Volume: 50, Issue:3 Topics: Animals; Apomorphine; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Flunarizine; Haloperidol; Male; Rats; Rats, Wistar; Stereotyped Behavior; Verapamil	1992
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2 Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Sulpiride	1992
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia. Clinical neuropharmacology, 1992, Volume: 15, Issue:6 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome	1992
[Subcutaneous apomorphine infusion in the treatment of Parkinson disease]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1992, Aug-25, Volume: 81, Issue:35 Topics: Aged; Antiparkinson Agents; Apomorphine; Dyskinesia, Drug-Induced; Female; Humans; Infusion Pumps; Injections, Subcutaneous; Male; Middle Aged; Parkinson Disease	1992
[Dopa-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated hemiparkinsonian monkeys]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1992, Volume: 25, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamines; Animals; Apomorphine; Benserazide; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca mulatta; Parkinson Disease, Secondary	1992
Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. Psychiatry research, 1992, Volume: 41, Issue:3 Topics: Adult; Aged; Apomorphine; Brain; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Middle Aged; Neurologic Examination; Prolactin; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology	1992
Paradoxical akinetic response to apomorphine in parkinsonism. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:5 Topics: Apomorphine; Benserazide; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1992
Neurochemical basis for the absence of overt "stereotyped" behaviors in rats with up-regulated striatal D2 dopamine receptors. Clinical neuropharmacology, 1991, Volume: 14, Issue:3 Topics: Animals; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dyskinesia, Drug-Induced; Kinetics; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereotyped Behavior; Tyrosine 3-Monooxygenase; Up-Regulation	1991
Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile. European neurology, 1990, Volume: 30 Suppl 1 Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Bromocriptine; Ceruletide; Dyskinesia, Drug-Induced; Levodopa; Male; Neurotoxins; Neurotransmitter Agents; Nitriles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic	1990
Buspirone in the treatment of levodopa induced dyskinesias. Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:4 Topics: Adult; Aged; Apomorphine; Buspirone; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease	1991
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease. Neurology, 1990, Volume: 40, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxazines; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri	1990
Apomorphine-induced dyskinesias after excitotoxic caudate-putamen lesions and the effects of neural transplantation in non-human primates. Progress in brain research, 1990, Volume: 82 Topics: Animals; Apomorphine; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Fetal Tissue Transplantation; Huntington Disease; Ibotenic Acid; Male; Papio; Putamen; Rats; Species Specificity; Transplantation, Heterologous	1990
Preliminary report on adrenal medullary grafting and cografting with sural nerve in the treatment of hemiparkinson monkeys. Progress in brain research, 1990, Volume: 82 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenal Medulla; Animals; Apomorphine; Behavior, Animal; Carbidopa; Caudate Nucleus; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Macaca mulatta; Motor Activity; Parkinson Disease; Sural Nerve; Transplantation, Heterotopic	1990
['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine]. Nederlands tijdschrift voor geneeskunde, 1990, May-05, Volume: 134, Issue:18 Topics: Aged; Antiparkinson Agents; Apomorphine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Parkinson Disease	1990
Neuroleptic drugs and their action on different neuronal pathways. The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2 Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Brain; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Ergolines; gamma-Aminobutyric Acid; Humans; Motor Activity; Neural Pathways; Pergolide; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission	1985
The pathophysiology of tardive dyskinesia. The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2 Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Guinea Pigs; Haloperidol; Humans; Receptors, Dopamine; Stereotyped Behavior; Thioridazine; Time Factors	1985
Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels. Psychopharmacology, 1985, Volume: 86, Issue:1-2 Topics: Animals; Apomorphine; Corpus Striatum; Cyclic AMP; Dyskinesia, Drug-Induced; Haloperidol; Homovanillic Acid; Humans; Male; Phenylacetates; Phenytoin; Psychoses, Substance-Induced; Rats; Rats, Inbred Strains; Receptors, Dopamine	1985
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. European journal of pharmacology, 1988, May-20, Volume: 150, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Benzazepines; Brain Chemistry; Dopamine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Spiperone	1988
Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol. European journal of pharmacology, 1988, Aug-24, Volume: 153, Issue:2-3 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dyskinesia, Drug-Induced; Ergolines; Female; Haloperidol; Quinpirole; Receptors, Dopamine	1988
Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. British journal of pharmacology, 1985, Volume: 85, Issue:4 Topics: Alprostadil; Animals; Apomorphine; Corpus Striatum; Dinoprost; Dinoprostone; Dopamine; Dyskinesia, Drug-Induced; Functional Laterality; Guinea Pigs; Male; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Tetrahydronaphthalenes	1985
SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models. Life sciences, 1985, Dec-23, Volume: 37, Issue:25 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benzimidazoles; Chlorpromazine; Chlorprothixene; Drug Synergism; Dyskinesia, Drug-Induced; Haloperidol; Male; Metoclopramide; Mice; Motor Activity; Saimiri; Stereotyped Behavior	1985
Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys. Neuroscience letters, 1986, Feb-28, Volume: 64, Issue:2 Topics: Animals; Apomorphine; Drug Interactions; Dyskinesia, Drug-Induced; Estradiol; Female; Haloperidol; Macaca fascicularis; Receptors, Dopamine	1986
[Experimental dyskinesia of the mandible: central and oral nerve stimulation in induced reflexes in the rat]. Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia, 1985, Volume: 81, Issue:4 Topics: Animals; Apomorphine; Bruxism; Dyskinesia, Drug-Induced; Masseter Muscle; Mastication; Masticatory Muscles; Mouth; Physical Stimulation; Rats	1985